1. Articles in category: Other Business News

    1-24 of 1290 1 2 3 4 ... 52 53 54 »
    1. New Ultra-fast Digitizers gets a boost with peer-to-peer streaming

      New Ultra-fast Digitizers gets a boost with peer-to-peer streaming

      Anyone working in experimental science or with high-end sampling applications at the limits of modern ultra-fast digitizers will soon realize the performance benefits to be gained from peer-to-peer (P2P) streaming. Rather than data being arbitrated between the host and its local memory, P2P streaming side-tracks the host enabling direct data transfers between expansion cards in modern PC backplanes. In this white paper, we explore the pitfalls of PCIe data transfer – how maximum throughput is impacted by host architecture, protocol coding, and payload size. 

      Read Full Article
    2. Luneau Technology Group merges with Optovue

      Luneau Technology Group merges with Optovue

      Luneau Technology Group announced that its merger with Optovue Inc. will enable the two companies to offer a comprehensive portfolio of health solutions to eye care providers. “We’re two agile companies with a startup mentality of innovation and flexibility,” Marc Abitbol, PhD, CEO of the newly merged company, said in a press release. “Together, we now have a full pipeline that covers everything for visual health. Optovue’s OCT expertise, stellar reputation and primary position in the medical eye care market and complementary portfolio of products make us an ideal partner, so our combined company can offer complete end-to-end ...

      Read Full Article
      Mentions: Optovue
    3. Next Generation ASC Laser Controller Solution Is Now Available

      Next Generation ASC Laser Controller Solution Is Now Available

      ARGES, a product brand of Novanta Corporation (“Novanta”), announces the addition of its new laser controller, ASC Generation 4 to its ASC series portfolio. This new controller features powerful performance thanks to updated electronics, changeable multi-functional interface boards for added flexibility, and open platform with embedded Linux OS. This controller solution is compatible with all ARGES scan heads, lasers, and sub-systems. Packed with enhanced features and performance, this next generation controller works seamlessly with our proprietary software, InScript for a complete laser control solution. Our cross-collaborative team has worked tirelessly to develop a controller platform that enables a new level ...

      Read Full Article
    4. PHC Corporation of North America and SCREEN Partner to Promote 3D Live Cell Imaging in North America

      PHC Corporation of North America and SCREEN Partner to Promote 3D Live Cell Imaging in North America

      PHC Corporation of North America (PHCNA) and SCREEN Holdings Co., Ltd. have today announced the formation of a partnership to market and sell the SCREEN Cell3iMager series of live-cell imaging systems in North America. These innovative ex vivo imaging instruments enable organoid and spheroid imaging with excellent accuracy using high-throughput, high-speed, and non-invasive technology for cellular research, drug discovery, cosmetic and biopharmaceutical applications. SCREEN’s instrument portfolio includes high speed bright-field spheroid imagers, multi-fluorescence imaging in 2D and 3D, as well as live-cell imaging by optical coherence tomography (OCT). The instruments will be available alongside PHCbi’s current portfolio of ...

      Read Full Article
    5. Wasatch Photonics announces the appointment of Neil Anderson as Vice President, Gratings and OCT

      Wasatch Photonics announces the appointment of Neil Anderson as Vice President, Gratings and OCT

      Wasatch Photonics is pleased to announce and welcome Neil Anderson, Ph.D. as the new Vice President of Gratings and OCT. In this role, Neil will be responsible for commercial leadership and growth of the company’s transmission gratings and optical coherence tomography business, working with the teams in Logan, UT, and Morrisville, NC, to develop innovative product solutions matched to current and emerging market needs in laser pulse compression, optical coherence tomography (OCT), astronomy, and photonics. Neil is a well-known and respected figure in the optics and photonics industry and brings 15 years of experience supporting customers with optical ...

      Read Full Article
    6. Perimeter Medical Imaging AI Reports Second Quarter 2021 Financial Results and Provides ...

      Perimeter Medical Imaging AI Reports Second Quarter 2021 Financial Results and Provides ...

      Summary of Second Quarter 2021 Financial Results: All of the amounts are expressed in Canadian dollars unless otherwise indicated and are presented in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS”) applicable to the preparation of interim financial statements, including International Accounting Standard (“IAS”) 34, Interim Financial Reporting. Operating expenses for the three months ended June 30, 2021 were $3,056,431 compared to $1,997,959 during the same period in 2020. The net loss for the three months ended June 30, 2021 of $3,238,722 compared to $4,659,480 ...

      Read Full Article
    7. Avinger Announces 510(k) Filing for New Lightbox 3 Imaging Console

      Avinger Announces 510(k) Filing for New Lightbox 3 Imaging Console

      Smaller Footprint, Improved User Experience and Lower Cost to Drive Adoption Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the submission of a 510(k) application to the U.S. Food & Drug Administration (FDA) for its new Lightbox 3 imaging console. "Avinger's Lightbox 3 represents an important leap forward in imaging, portability and capability," commented Jeff Soinski, Avinger's President and CEO. "The Lightbox 3's compact size, next generation laser system and streamlined workflows are anticipated to ...

      Read Full Article
      Mentions: Avinger
    8. Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the Heart

      Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the Heart

      Ultreon™ 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using Artificial Intelligence The new intuitive interface provides step-by-step guidance to enhance ease of use When combined with Abbott's Dragonfly OpStar™ imaging catheter and PressureWire X™, the platform provides physicians with a comprehensive set of tools to provide better patient care Abbott (NYSE: ABT ) today announced it has received U.S. Food and Drug Administration (FDA) clearance for its latest optical coherence tomography (OCT) imaging platform powered by the company's new Ultreon Software. This innovative imaging software combines OCT with artificial ...

      Read Full Article
      Mentions: Abbott FDA
    9. Carl Zeiss Meditec Takes Insight Photonics Solutions to Court for Breach of Contract Seeking $150M in Damages

      Carl Zeiss Meditec Takes Insight Photonics Solutions to Court for Breach of Contract Seeking $150M in Damages

      UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK CARL ZEISS MEDITEC, INC., Civil Action No. Plaintiff, Complaint v. INSIGHT PHOTONICS SOLUTIONS, INC., Defendant. Plaintiff Carl Zeiss Meditec, Inc. ("Zeiss"), by its attorneys, Dorsey & Whitney LLP, for its Complaint against Defendant Insight Photonics Solutions, Inc. ("Insight"), states as follows: INTRODUCTION 1. This action arises out of Insight's willful and bad faith breaches of a 2017 development agreement (the "Development Agreement") by and among Zeiss, Insight, and a joint venture between Zeiss and Insight, called Ophthalmic Laser Engines, LLC ("OLE"). Under the Development Agreement, Insight was obligated to develop ophthalmic ...

      Read Full Article
    10. Notal Vision announces publication of first prospective longitudinal pilot study of daily self-imaging with patient-operated Home OCT in wet AMD patients

      Notal Vision announces publication of first prospective longitudinal pilot study of daily self-imaging with patient-operated Home OCT in wet AMD patients

      Notal Vision, Inc. announced today that results from the first prospective longitudinal pilot study of daily, home-based self-imaging with their investigational, patient-operated Home OCT for wet age-related macular degeneration (AMD) patients have been published in Ophthalmology Science . 1 The technology is designed to provide retina specialists with remote retinal OCT scans and fluid volume trajectories to support the management of patients with wet AMD, complementing existing standard of care treatments as well as emerging longer acting drugs and drug delivery systems. The study evaluated the ability of subjects to perform sequential daily self-imaging of their eyes with the user-friendly, tele-connected ...

      Read Full Article
      Mentions: FDA Notal Vision
    11. Anrtisu Introduces a New Swept Light Source

      Anrtisu Introduces a New Swept Light Source

      Anritsu released the swept light source for OCT applications on 1st July 2021. More information can be found in the following links. https://www.anritsu.com/en-US/sensing-devices/products/swept-light-source Anritsu Wavelength Swept Light Source Operation Principles and OFDR Measurement Application Document Anritsu Wavelength Swept Light Source Measurement Applications Document

      Read Full Article
    12. Perimeter Medical Imaging AI Announces Important Milestone with Commercial-Scale Manufacturing of Perimeter S-Series OCT Now Underway

      Perimeter Medical Imaging AI Announces Important Milestone with Commercial-Scale Manufacturing of Perimeter S-Series OCT Now Underway

      Perimeter Medical Imaging AI, Inc. , a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, today announced that it has successfully completed the technology transfer of its manufacturing process for the production of its optical coherence tomography (OCT) imaging systems with Minnetronix Medical, a leading medical technology and operations partner to global medical device companies. \ Commercial-scale manufacturing of Perimeter S-Series OCT now underway (Photo: Business Wire) Jeremy Sobotta, Perimeter’s Chief Executive Officer stated, “The completed technology transfer marks a significant achievement for Perimeter. For the first time, the ...

      Read Full Article
    13. Hospital Hit With $1.1M Verdict Over Patient Death

      Hospital Hit With $1.1M Verdict Over Patient Death

      An Illinois jury has awarded a $1.1 million verdict to the family of a 75-year-old man who died following a procedure at OSF St. Anthony Medical Center, closing out a trial that had been delayed for eight months as a result of the COVID-19 pandemic. Jan Skowronski , an employee of OSF Multi-Specialty Group, which runs the hospital. The complaint alleged that Skowronski used an uncommon imaging procedure known as optical coherence tomography, or OCT, that required multiple catheter positioning requests and created a large, fatal tear in one of Powder's arteries

      Read Full Article
    14. Notal Vision raises up to $60 million to support development of its Home OCT technology and commercial growth of its ForeseeHome AMD Monitoring Program

      Notal Vision raises up to $60 million to support development of its Home OCT technology and commercial growth of its ForeseeHome AMD Monitoring Program

      Notal Vision, Inc., a privately held ophthalmic home monitoring services provider focused on early disease detection and treatment monitoring is pleased to announce the closing of a Series D financing co-led by Soleus Capital and the company’s majority shareholder Ganot Capital. Existing shareholders Elron and Evergreen contributed significantly to the round. The investment supports the commercial growth of the company’s current service, the ForeseeHome AMD Monitoring Program, as well as the go-to-market strategy for its Home OCT pipeline technology. “We believe the Home OCT device from Notal Vision has the potential to transform care for millions of patients ...

      Read Full Article
      Mentions: Notal Vision
    15. Perimeter Medical Imaging AI Reports First Quarter 2021 Financial Results and Provides Corporate Update

      Perimeter Medical Imaging AI Reports First Quarter 2021 Financial Results and Provides Corporate Update

      All of the amounts are expressed in Canadian dollars unless otherwise indicated and are presented in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS”) applicable to the preparation of interim financial statements, including International Accounting Standard (“IAS”) 34, Interim Financial Reporting. Operating expenses for the three months ended March 31, 2021 were $3,820,246 compared to $1,730,564 during the same period in 2020. The net loss for the three months ended March 31, 2021 was $4,015,732 compared to $1,792,611 for the same period in 2020. For ...

      Read Full Article
    16. Business eyes a rosy future

      Business eyes a rosy future

      FOR the past 40 years, Lithgow Optical has been a mainstay in Lithgow's Main Street, under the former owner Warren Rissman who has retired. Brad Cherrie has been the optometrist working in the current business for ten years. His special interests include working with children, especially those with vision related learning issues. Owner George Gatt has a background in manufacturing. George's business plans include developing the health care aspect in the business. "New technology being rolled out includes an OCT [optical coherence tomography], which is scanning technology similar to MRI imaging, to detect and monitor eye diseases such ...

      Read Full Article
    17. Guilford scientists create non-invasive test that detects health issues through the eyes

      Guilford scientists create non-invasive test that detects health issues through the eyes

      magine a doctor being able to diagnose health conditions, even diseases without drawing blood or doing anything invasive. Some scientists at Tesseract Health, Inc. in Guilford have developed a high-tech tool they say will do that. Tesseract Health’s Chief Medical Officer says it’s the window to a person’s health. “It’s the only place in the human body where one can directly see arteries, veins, capillaries and nerves,” says Dr. David Rosenthal, Tesseract Health’s chief medical officer. The device is called the Tesseract iC. It’s inventors call the diagnostic tool a next-generation diagnostic tool for ...

      Read Full Article
    18. Webinar on Taiwan digital health solutions calls for healthcare rethink

      Webinar on Taiwan digital health solutions calls for healthcare rethink

      This week, five medtech brands from Taiwan presented their latest digital health innovations in a webinar organized by TAITRA (Taiwan External Trade Development Council), Taiwan’s leading trade promotion organization, and Taiwan’s Bureau of Foreign Trade, Ministry of Economic Affairs. The S100 Image System A year into the pandemic, “Taiwan still remains as one of the best-managed societies against COVID-19, having one of the lowest mortality rates and one of the lowest infection rates, partially based on Taiwan’s digital health development,” remarked Dr. Yu-Chuan Jack Li, a dermatologist, professor and President-Elect of the International Medical Informatics Association, during ...

      Read Full Article
    19. Perimeter Medical Imaging AI Reports 2020 Financial Results and Provides Corporate Update

      Perimeter Medical Imaging AI Reports 2020 Financial Results and Provides Corporate Update

      Summary 2020 Financial Results All of the amounts are expressed in Canadian dollars unless otherwise indicated and are presented in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS”) applicable to the preparation of interim financial statements, including International Accounting Standard (“IAS”) 34, Interim Financial Reporting. Operating expenses for the year ended 2020 were $10,159,444 compared to $8,708,853 during the previous year. For the year ended December 31, 2020, the net loss was $7,885,966 compared to $10,342,686 in the prior year. For the year ended December ...

      Read Full Article
    20. Heidelberg Engineering and RetInSight to offer AI-based OCT fluid quantification solution

      Heidelberg Engineering and RetInSight to offer AI-based  OCT fluid quantification solution

      Heidelberg Engineering GmbH and RetInSight GmbH intend to interface the RetInSight AI-based fluid monitor application with the Heidelberg Engineering product portfolio, using cloud exchange and application marketplace technologies. Both companies see great potential in the combination of RetInSight’s AI expertise with Heidelberg Engineering’s high-quality images and data management experience. RetInSight utilizes a novel, proprietary algorithm, that supports the detection, localization and quantification of intra- and subretinal fluid in OCT images in an accurate and reliable manner1. The fluid monitor application aims to facilitate early diagnosis and therapeutic guidance in the most common diseases of the retina, i.e ...

      Read Full Article
    21. Abbott launches AI-powered coronary OCT imaging system in Europe

      Abbott launches AI-powered coronary OCT imaging system in Europe

      To give clinicians a quick, cross-sectional look into potential blockages of the heart’s major arteries, Abbott has combined digital imaging technology with artificial intelligence to build an automated system for cardiac procedures. The company’s Ultreon software relies on catheters equipped with optical coherence tomography, which uses laser light to scan the interior of a blood vessel and the immediately surrounding tissues to detect calcium and plaque deposits, while also instantly measuring the diameter of an artery. The system—which has now received a CE Mark in Europe—is designed to provide surgeons with prompt information during the placement ...

      Read Full Article
    22. New Publications Highlight Clinical Benefits of Avinger PAD Therapies

      New Publications Highlight Clinical Benefits of Avinger PAD Therapies

      Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the publication of two clinical studies in peer-reviewed journals, further supporting the clinical benefits of its therapeutic devices. The studies were based on separate clinical case series conducted by physicians at the Division of Cardiovascular Disease and Endovascular Medicine at the Einstein Medical Center in Philadelphia, Pennsylvania. "These two studies demonstrate the utility of Avinger's OCT-guided approach for the treatment of PAD in complex and challenging cases and patient populations ...

      Read Full Article
    23. Tesseract Health Closes Oversubscribed $80 Million Series B Financing

      Tesseract Health Closes Oversubscribed $80 Million Series B Financing

      Tesseract HealthTM Inc. has raised $80 million in an oversubscribed Series B financing round -- with support from investors including Foresite Capital, Glenview Capital, and Opaleye -- to advance the development of the company’s groundbreaking Tesseract iC™ eye-imaging diagnostic technology platform. The funds will be used to conduct research to advance the Tesseract iC platform, accelerate the company’s push to obtain US and international regulatory clearances, and ramp up manufacturing. The funds will also be used to further enhance Tesseract’s unique AI capabilities and prepare the company for commercial launch. The Tesseract iC platform (not yet cleared by the ...

      Read Full Article
    24. Perimeter Medical Imaging AI Receives U.S. FDA Breakthrough Device Designation for its Optical Coherence Tomography (OCT) Imaging System with ImgAssist AI

      Perimeter Medical Imaging AI Receives U.S. FDA Breakthrough Device Designation for its Optical Coherence Tomography (OCT) Imaging System with ImgAssist AI

      Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, announced today that the U.S. Food and Drug Administration (FDA) has granted the company a Breakthrough Device Designation for its Optical Coherence Tomography (OCT) Imaging System coupled with ImgAssist AI. Perimeter is advancing its proprietary, next-gen artificial intelligence technology and machine learning tools through clinical development under its ATLAS AI project, which is made possible, in part, by a $7.4 million grant ...

      Read Full Article
    1-24 of 1290 1 2 3 4 ... 52 53 54 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Popular Articles

  3. OCT Companies in the News

    1. (1 articles) Optovue
    2. (1 articles) Perimeter Medical Imaging
    3. (1 articles) Wasatch Photonics
    4. (1 articles) SCREEN Life Sciences
    5. (1 articles) Teledyne SP Devices
    6. (1 articles) Cambridge Technology
    7. (1 articles) Novanta
    8. (1 articles) Arges
    9. (1 articles) Screen Life Sciences
    10. (1 articles) PHC Corporation